Published in J Clin Psychiatry on January 01, 1999
Neuroimaging in anxiety disorders. J Neural Transm (Vienna) (2008) 0.86
Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder. Eur J Nucl Med Mol Imaging (2003) 0.84
The genetic studies of obsessive-compulsive disorder and its future directions. Yonsei Med J (2006) 0.80
Diminished support for linkage between manic depressive illness and X-chromosome markers in three Israeli pedigrees. Nat Genet (1993) 3.40
Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Mol Psychiatry (1999) 2.80
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet (1995) 1.90
Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol Psychiatry (2006) 1.89
Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet (2000) 1.68
Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry (1997) 1.66
Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia. Acta Psychiatr Scand (2014) 1.56
Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold. J Clin Psychiatry (1996) 1.53
Neuroendocrine evidence for age-related decline in central serotonergic function. Neuropsychopharmacology (1999) 1.49
Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry (2004) 1.46
A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry (2000) 1.45
A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet (2001) 1.42
Ethical issues in genetic linkage studies of psychiatric disorders. Br J Psychiatry (1992) 1.40
Biological psychiatry in Israel: approaching the challenge of maturity. Isr J Psychiatry Relat Sci (1995) 1.39
Phospholipase A2 activity in Epstein-Barr virus-transformed lymphoblast cells from schizophrenic patients. Biol Psychiatry (1991) 1.38
Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry (2001) 1.29
Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. Am J Psychiatry (1998) 1.25
Environmental stress and psychiatric illness. Biomed Pharmacother (2000) 1.19
Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12. Mol Psychiatry (2003) 1.19
Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry (2006) 1.14
Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions. Mol Psychiatry (2009) 1.12
Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am J Hum Genet (1998) 1.09
A comprehensive linkage analysis of chromosome 21q22 supports prior evidence for a putative bipolar affective disorder locus. Am J Hum Genet (1999) 1.07
Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism. Pharmacogenomics J (2005) 1.04
Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry (1997) 1.04
Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet (1998) 1.01
Post-traumatic stress disorder and depression. An analysis of comorbidity. Br J Psychiatry (1997) 1.01
Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function. Genes Brain Behav (2007) 0.99
Constitutive heterochromatin of chromosome 1 and Duffy blood group alleles in schizophrenia. Am J Med Genet (1995) 0.97
Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits. Schizophr Res (2011) 0.95
Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Mol Psychiatry (2006) 0.94
Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression. Br J Psychiatry (1992) 0.93
An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline. Isr J Psychiatry Relat Sci (2000) 0.92
Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes. Am J Med Genet B Neuropsychiatr Genet (2004) 0.92
Age-related changes in brain perfusion of normal subjects detected by 99mTc-HMPAO SPECT. Neuroradiology (1998) 0.91
Maternal transmission disequilibrium of the glutamate receptor GRIK2 in schizophrenia. Neuroreport (2004) 0.90
Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry (1990) 0.90
Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia. Mol Psychiatry (2006) 0.90
The different trajectories of antipsychotic response: antipsychotics versus placebo. Psychol Med (2010) 0.90
Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry (1987) 0.90
Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility. Psychopharmacology (Berl) (2000) 0.89
Blunted temperature and cortisol responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy. Psychoneuroendocrinology (2000) 0.89
Personality features in essential hyperhidrosis. Int J Psychiatry Med (1980) 0.88
The impact of parental death versus separation from parents on the mental health of Israeli adolescents. Compr Psychiatry (2001) 0.87
Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry (1999) 0.87
Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol (2000) 0.86
Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism. Pharmacogenomics J (2006) 0.86
A pedigree series for mapping disease genes in bipolar affective disorder: sampling, assessment, and analytic considerations. Psychiatr Genet (1994) 0.86
Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy. Psychopharmacology (Berl) (1995) 0.86
Post-traumatic stress disorder following combat exposure: clinical features and psychopharmacological treatment. Br J Psychiatry (1986) 0.86
Hyperhidrosis: a review of its psychological aspects. Psychosomatics (1977) 0.86
Loss of cholinergic neurons in the rat neocortex produces deficits in passive avoidance learning. Pharmacol Biochem Behav (1983) 0.85
Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia. Pharmacogenomics J (2003) 0.85
Potential linkage for schizophrenia on chromosome 22q12-q13: a replication study. Am J Med Genet (1995) 0.85
Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study. Biol Psychiatry (2001) 0.85
Psychological variables as predictors of rubella antibody titers and fatigue--a prospective, double blind study. J Psychiatr Res (1999) 0.84
The trace amine receptor 4 gene is not associated with schizophrenia in a sample linked to chromosome 6q23. Mol Psychiatry (2006) 0.84
Role of genetic variants in the CHRNA5-CHRNA3-CHRNB4 cluster in nicotine dependence risk: importance of gene-environment interplay. Mol Psychiatry (2009) 0.84
A follow-up linkage study supports evidence for a bipolar affective disorder locus on chromosome 21q22. Am J Med Genet (2001) 0.84
Excitement and confusion on chromosome 6q: the challenges of neuropsychiatric genetics in microcosm. Mol Psychiatry (2005) 0.84
Social adjustment and self-esteem of bipolar patients: a multicentric study. J Affect Disord (2004) 0.83
Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy. Biol Psychiatry (1984) 0.83
Verbal and non-verbal recall by depressed and euthymic affective patients. Psychol Med (1986) 0.83
Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. J Nucl Med (1996) 0.82
Social adjustment and self-esteem in remitted patients with unipolar and bipolar affective disorder: a case-control study. Compr Psychiatry (1999) 0.82
Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia. Pharmacogenomics J (2007) 0.82
Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia. Hum Hered (1997) 0.81
Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects. Psychopharmacology (Berl) (1995) 0.81
Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects. Eur Neuropsychopharmacol (1997) 0.81
Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression. Psychopharmacology (Berl) (1981) 0.81
Association analysis of NOTCH4 loci in schizophrenia using family and population-based controls. Nat Genet (2001) 0.81
Age and the relationship of dopamine D3, serotonin 2C and serotonin 2A receptor genes to abnormal involuntary movements in chronic schizophrenia. Mol Psychiatry (2002) 0.81
Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium. Biol Psychiatry (1985) 0.81
Treatment of chronic schizophrenia with cyproheptadine. Biol Psychiatry (1989) 0.81
Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region. Pharmacogenomics J (2008) 0.80
Chronic clomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: relationship to serotonin autoreceptor activity. J Pharmacol Exp Ther (1999) 0.80
Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain. Neuroreport (2000) 0.80
Increased prevalence of negative life events in subtypes of major depressive disorder. Compr Psychiatry (2001) 0.80
A possible susceptibility locus for bipolar affective disorder in chromosomal region 10q25--q26. Mol Psychiatry (2001) 0.80
Support for association of HSPG2 with tardive dyskinesia in Caucasian populations. Pharmacogenomics J (2011) 0.80
Genetic linkage analysis of schizophrenia using chromosome 11q13-24 markers in Israeli pedigrees. Am J Med Genet (1995) 0.80
Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively. Neuropharmacology (2000) 0.79
Post-partum psychosis in adult GM2 gangliosidosis. A case report. Br J Psychiatry (1988) 0.79
Cerebral hypoperfusion in medication resistant, depressed patients assessed by Tc99m HMPAO SPECT. J Affect Disord (1996) 0.79
Salbutamol treatment of depression. Adv Biochem Psychopharmacol (1982) 0.79
Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo. Eur J Pharmacol (1999) 0.79
Lithium amelioration of reserpine-induced hypoactivity in rats. Int Pharmacopsychiatry (1980) 0.79
Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions. Pharmacogenomics J (2010) 0.79
Clinical implications of research on the mechanism of action of lithium. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.79
Post-traumatic stress disorder: issues of co-morbidity. J Psychiatr Res (1991) 0.79
Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. J Nerv Ment Dis (1991) 0.79
Treatment of unipolar major depression: Algorithms for pharmacotherapy. Int J Psychiatry Clin Pract (1997) 0.79
Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonist and antidepressants. J Pharmacol Exp Ther (1992) 0.79
Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study. Arch Gen Psychiatry (1984) 0.79
Association between hSKCa3 and schizophrenia not confirmed by transmission disequilibrium test in 193 offspring/parents trios. Mol Psychiatry (1999) 0.79
Influence of socioeconomic status on behavioral, emotional and cognitive effects of rubella vaccination: a prospective, double blind study. Psychoneuroendocrinology (1998) 0.79
HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study. Mol Psychiatry (2007) 0.79